Filtered By:
Source: International Journal of Cardiology
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 880 results found since Jan 2013.
A critical view on correlation between left atrial outpouching structures and ischemic brain alterations
I have read with great interest the recent article by Celik et al. [1] assessing the correlation between the left atrial diverticulas and left-sided pouches with ischemic brain lesions. In this issue, I would like to draw attention to a few points that need attention. Firstly, the TOAST classification [2] which is currently used basically for etiology of stroke, is not considered in this study and only cardioembolic and cryptogenic subtypes of stroke are needed to be considered. Large-artery atherosclerosis such as carotid artery diseases or other determined etiologies for example, haematological pathologies should be excluded.
Source: International Journal of Cardiology - October 11, 2020 Category: Cardiology Authors: Erdi Babayi ğit Tags: Letter to the Editor Source Type: research
Association between cardioplegia and postoperative atrial fibrillation in coronary surgery
The aim of this multicenter study was to evaluated whether cold or warm cardioplegia are associated with postoperative atrial fibrillation (POAF) and the prognostic role of the latter on early stroke and neurological mortality.
Source: International Journal of Cardiology - October 2, 2020 Category: Cardiology Authors: Michele Di Mauro, Antonio M. Calafiore, Antonino Di Franco, Francesco Nicolini, Francesco Formica, Roberto Scrofani, Carlo Antona, Antonio Messina, Giovanni Troise, Giovanni Mariscalco, Cesare Beghi, Michele De Bonis, Cinzia Trumello, Antonio Miceli, Matt Source Type: research
Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure
Atrial fibrillation (AF) and heart failure (HF) carry a poor prognosis in acute ischaemic stroke (AIS). The impact of revascularisation therapies on outcomes in these patients is not fully understood.
Source: International Journal of Cardiology - October 1, 2020 Category: Cardiology Authors: Tiberiu A. Pana, Mohamed O. Mohamed, Allan B. Clark, Eoin Fahy, Mamas A. Mamas, Phyo K. Myint Source Type: research
The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation
Atrial fibrillation (AF) is the most common arrhythmia, with a substantial rise in global incidence and prevalence. Ischemic stroke is a frequent complication of AF, since AF perfectly fulfills Virchow's triad of blood stasis, vascular damage and hypercoagulation, making oral anticoagulation (OAC) obligatory for stroke prevention. Direct oral anticoagulants (DOAC), such as dabigatran, which inhibits thrombin, and apixaban, edoxaban and rivaroxaban, which block the activated coagulation factor X (FXa), have some advantages and are largely replacing coumarin-based OAC.
Source: International Journal of Cardiology - September 30, 2020 Category: Cardiology Authors: Anke C. Fender, Dobromir Dobrev Tags: Editorial Source Type: research
Impact of disease stage on the performance of strain markers in the prediction of atrial fibrillation
Assessing atrial fibrillation (AF) risk may be useful in primary prevention (PP; people with risk factors) and secondary prevention (SP; eg. embolic stroke of unknown source). We sought whether disease stage influenced the prediction of AF by echocardiography.
Source: International Journal of Cardiology - September 24, 2020 Category: Cardiology Authors: Satish Ramkumar, Faraz Pathan, Hiroshi Kawakami, Ayame Ochi, Hong Yang, Elizabeth L. Potter, Thomas H. Marwick Source Type: research
Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study
Atrial fibrillation (AF) is a frequent comorbidity in malignant patients. Anticancer therapies complicate anticoagulant strategy. We evaluated the safety and efficacy of long-term use of direct oral anticoagulants (DOACs) in breast cancer women.
Source: International Journal of Cardiology - September 11, 2020 Category: Cardiology Authors: Renata Pacholczak-Madej, Stanis ława Bazan-Socha, Lech Zaręba, Anetta Undas, Jerzy Dropiński Source Type: research
Determinants of outcome in patients with heart failure with reduced ejection fraction & secondary mitral regurgitation
The outcome of secondary mitral regurgitation (MR) in patients with heart failure is poor. Survival is related to the severity of MR. We sought to investigate the effect of left ventricular contractility, the ratio of left ventricular end-diastolic volume (LVEDV) to effective orifice area (EROA) and the ratio of regurgitant volume (RVol) to stroke volume (SV) on cardiovascular survival.
Source: International Journal of Cardiology - September 6, 2020 Category: Cardiology Authors: Athina Chasapi, Nikos Karogiannis, Spyridon Zidros, Kush Patel, Guy Lloyd, Sanjeev Bhattacharyya Source Type: research
HIIT for post-COVID patients within cardiac rehabilitation: Response to letter to the editor
We thank Li and colleagues for their comments regarding our recent research into the benefits of incorporating high-intensity interval training (HIIT) into cardiac rehabilitation for patients with coronary artery disease (CAD) [1]. In recent years, HIIT has proven popular in the general community and has been studied across a wide array of cardiovascular (CV)-related disorders, such as hypertension [2,3], stroke [4,5], type II diabetes [6] and non-alcoholic fatty liver disease [7]. This is due to compounding, compelling evidence of the efficacy of HIIT on CV outcomes such as reduced blood pressure, lowered body fat, improv...
Source: International Journal of Cardiology - August 29, 2020 Category: Cardiology Authors: Andrew Keech, Kimberley Way, Katie Holgate, Jennifer Fildes, Praveen Indraratna, Jennifer Yu Tags: Letter to the Editor Source Type: research
Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population,Data from the COOL-AF Thailand registry
Patients with AF and chronic kidney disease(CKD) encountered increased risks of stroke, bleeding, morbidity, and overall mortality. Oral anticoagulation in these populations definitely enhances major bleeding but the benefit of stroke reduction remained inconclusive.The aim of this study is to evaluate the effect of oral anticoagulation (OAC) on the 2-year cardiovascular outcomes in patients with AF and CKD .
Source: International Journal of Cardiology - August 19, 2020 Category: Cardiology Authors: Thoranis Chantrarat, Rungroj Krittayaphong Source Type: research
Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study
Underuse of anticoagulants in ischemic stroke patients with atrial fibrillation (AF) and/or rheumatic heart disease (RHD) is a global concern, especially in China. However, the extent to which anticoagulants are underused in AF and/or RHD-related ischemic stroke in China has not been well characterized. We aimed to explore the temporal trends of AF and/or RHD-related ischemic stroke patients, anticoagulation use and factors related to suboptimal use of anticoagulants in a Chinese population.
Source: International Journal of Cardiology - August 15, 2020 Category: Cardiology Authors: Junfeng Liu, Yanan Wang, Wen Guo, Yajun Cheng, Shihong Zhang, Bo Wu, Ming Liu Source Type: research
The hospitalizations in hypertrophic cardiomyopathy: “the dark side of the moon”.
Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left ventricular hypertrophy not solely explainable by abnormal loading condition [1,2]. Patients with HCM show a different clinical course, ranging from an asymptomatic status, with no adverse events and normal or extended longevity, to a symptomatic condition in which several disease complications can occur [3]. Among HCM patients which experience disease progression, 3 different pathways have been identified: refractory heart failure (HF), requiring surgical myectomy/alcohol ablation (obstructive HCM, OHCM) or heart transplant (non-obstructive HC...
Source: International Journal of Cardiology - August 14, 2020 Category: Cardiology Authors: Emanuele Monda, Giuseppe Limongelli Tags: Editorial Source Type: research
The hospitalizations in hypertrophic cardiomyopathy: “The dark side of the moon”
Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left ventricular hypertrophy not solely explainable by abnormal loading condition [1,2]. Patients with HCM show a different clinical course, ranging from an asymptomatic status, with no adverse events and normal or extended longevity, to a symptomatic condition in which several disease complications can occur [3]. Among HCM patients which experience disease progression, 3 different pathways have been identified: refractory heart failure (HF), requiring surgical myectomy/alcohol ablation (obstructive HCM, OHCM) or heart transplant (non-obstructive HC...
Source: International Journal of Cardiology - August 14, 2020 Category: Cardiology Authors: Emanuele Monda, Giuseppe Limongelli Tags: Editorial Source Type: research
Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke
To determine association of discharge antiplatelet therapy prescription with 1-year outcomes among patients with AF admitted with acute ischemic stroke and discharged without oral anticoagulation.
Source: International Journal of Cardiology - August 13, 2020 Category: Cardiology Authors: Kay-Won Chang, Ying Xian, Xin Zhao, Xiaojuan Mi, Roland Matsouaka, Lee H. Schwamm, Shreyansh Shah, Barbara L. Lytle, Eric E. Smith, Deepak L. Bhatt, Gregg C. Fonarow, Jonathan C. Hsu Source Type: research
Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease
Cardiovascular disease (CVD) is the most prevalent disease in Western countries and causes poor quality of life, substantial health-care resource utilisation, and premature mortality. In the last decades, many CV risk factors have been identified and addressed accordingly [1]. However, a large proportion of cardiovascular events remain unexplained by current risk scores based on the levels of traditional cardiovascular risk factors, suggesting that other important pathways might be involved in the initiation and evolution of atherosclerosis and its complications.
Source: International Journal of Cardiology - April 20, 2020 Category: Cardiology Authors: Nicola Riccardo Pugliese, Stefano Masi Tags: Editorial Source Type: research
A potential case for the routine assessment of cardiorespiratory fitness level in clinical practice
Cardiorespiratory fitness (CRF), as measured directly using respiratory gases, is the most accurate indicator of the ability to transport oxygen from the lung to the mitochondria to perform physical exercise. Left ventricular stroke volume, exercise heart rate, and arteriovenous oxygen differences at exercise are major determinants of CRF levels. Directly measured oxygen uptake (VO2), an objective and quantitative measure of CRF, is the gold standard for assessing the amount of oxygen consumption during exercise [1].
Source: International Journal of Cardiology - April 5, 2020 Category: Cardiology Authors: Jari A. Laukkanen, Setor K. Kunutsor Tags: Editorial Source Type: research
